St. Augustine, FL – Researchers currently conducting intracerebral hemorrhage clinical trials and/or case studies in furtherance of developing more efficacious treatment regimes based on pharmacologic and vitamin E intervention (mitigation of biochemical cascade myelin de-sheathing effect on axonal connectors) immediately post insult, throughout the entire treatment timeframe and requiring additional study subjects are encouraged to contact Myron D. Stokes, Publisher, eMOTION! REPORTS; email@example.com, 626-616-1655
- Patient status:
Subject for consideration is in 3rd week of critical condition following cerebral hemorrhage on 6/20/11. This is the third bleed for subject with previous events in 2005 and 2007, all of which patient encountered and survived systolic pressure exceeding 300 and diastolic above 150. Additional data available from primary care physician on request.
Abstract (Admission): “There is an intraparenchymal hematoma involving the right thalamic region exending into the superior right deep white matter. The hematoma measures approximately 3.5cm x 3.8 cm x 4.0 cm. There is a prominent rim of edema involving the deep white matter of the cerebrum.
“Intraventricular extension is noted with a prominent amount of blood with the right and left lateral ventricles, the third ventricle, the fourth ventricle. There is extension of blood into the peripontine cisterns bilaterally.
“There are probable obstructive hydrocephalic changes when compared to 3/19/11 (Acute ischemic infarct). There is approximate 6 to 8 mm of right to left subfalcine shift. No fractures are evident.”
Complete and current patient summary available from primary care physician on request.